Skip to main content

Animations

MJFF Publications

8951 - 8960 of 9140 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2025
  • 2019
  • 2018
  • 2024
  • 2024
  • 2021
  • 2020
  • 2024
  • Summary Details
    OPEN
    Title: Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-024-03270-6
    Citation Count: 49
  • Summary Details
    OPEN
    Title: TNF-NF-κB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.cell.2024.05.030
    Citation Count: 55
  • Summary Details
    OPEN
    Title: European and African ancestry-specific plasma protein-QTL and metabolite-QTL analyses identify ancestry-specific T2D effector proteins and metabolites
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41467-025-62463-w
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Parkinson's Disease Detection Using Isosurfaces-Based Features and Convolutional Neural Networks
    Journal Name: Frontiers in Neuroinformatics
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fninf.2019.00048
    Citation Count: 98
  • Summary Details
    OPEN
    Title: Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-018-0223-3
    Citation Count: 156
  • Summary Details
    OPEN
    Title: Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.92775
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Technical challenges in REM sleep microstructure classification: A study of patients with REM sleep behaviour disorder
    Journal Name: Journal of Sleep Research
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/jsr.14208
    Citation Count: 3
  • Summary Details
    OPEN
    Title: The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril ends
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-25966-w
    Citation Count: 84
  • Summary Details
    OPEN
    Title: Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-020-16564-3
    Citation Count: 166
  • Summary Details
    OPEN
    Title: Excitatory synaptic structural abnormalities produced by templated aggregation of α-syn in the basolateral amygdala
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.nbd.2024.106595
    Citation Count: 17
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.